Oral-Thrush: Oropharyngeal Candidiasis (OPC) and S-ECC

Sponsor
University of Pennsylvania (Other)
Overall Status
Recruiting
CT.gov ID
NCT05761197
Collaborator
Children's Hospital of Philadelphia (Other)
60
1
26.4
2.3

Study Details

Study Description

Brief Summary

The overall objective of this study is to investigate the association of early Candida infection (known as oral thrush or oropharyngeal candidiasis, OPC) in children during the first year of life with the onset and severity of severe early childhood caries (S-ECC).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The overall goal of this study is to conduct a longitudinal observational study to investigate the association of early OPC with the onset and severity of S-ECC to better understand the role of Candida (particularly C. albicans) in severe childhood caries. The investigators will test the hypothesis that OPC is associated with S-ECC by modifying the plaque microbiota and enhancing virulence in a manner that is conducive to the early development of the disease.

    For this study, a total of 60 infants (aged 6-15-month-old) with or without a history of OPC in their first year of life will be enrolled, based on the inclusion and exclusion criteria. Subjects will have their medical/dental history reviewed from medical records. At each study visit (Baseline, 6-month, 12-month, 18-month, and 24-month follow-ups), an oral examination including soft tissue and caries exam will be performed by a calibrated evaluator. Dental plaque/oral swab samples will be collected at each study visit. In addition, a comprehensive survey including demographic status, oral hygiene, diet, delivery, and feeding method as well as current medication usage will also be collected.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Association of Early Candida Infection (Oral Thrush) and Severe Early Childhood Caries (S-ECC)
    Actual Study Start Date :
    Feb 15, 2023
    Anticipated Primary Completion Date :
    Apr 30, 2025
    Anticipated Study Completion Date :
    Apr 30, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    Children with history of OPC

    Individuals in the non-OPC cohort will be age and sex-matched to individuals in the OPC cohort.

    Children without history of OPC

    Individuals in the OPC cohort will be age and sex-matched to individuals in the non-OPC cohort.

    Outcome Measures

    Primary Outcome Measures

    1. To explore the association between OPC and S-ECC onset and severity [24 months]

      Caries will be measured by ICDAS scoring system; Plaque and oral swab samples will be collected at each study visit (Baseline, 6-month, 12-month,18-month and 24-month follow-ups); Candida strains will be detected using culturing-dependent and -independent sequencing techniques.

    Secondary Outcome Measures

    1. To evaluate the influence of OPC on the oral microbiota [24 months]

      Microbiome profiling will be done by shot gun sequencing

    Other Outcome Measures

    1. To study the role of Candida on biofilm cariogenic properties [24 months]

      Candida-bacterial interaction in modulating biofilm development and virulence will be evaluated using validated experimental models

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 15 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male or female individuals at the age of 6-15-month-old

    • Must have at least one fully erupted tooth at baseline visit

    • Parent/guardian willing and able to provide informed consent

    • With or without a history of OPC (the study team will enroll 30 participants with and 30 participants without a history of OPC)

    Exclusion Criteria:
    • Presence of a systemic medical condition (e.g. Down syndrome etc.)

    • Presence of an orofacial deformity

    • Presence of dental caries

    • Use of systemic antimicrobial therapy within 30 days of the baseline visit

    • Presence of any condition which, in the opinion of the investigator, makes participation in the project not in the individual's best interest.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • University of Pennsylvania
    • Children's Hospital of Philadelphia

    Investigators

    • Principal Investigator: Yuan Liu, DDS, MS, PhD, Penn Dental School of Medicine

    Study Documents (Full-Text)

    More Information

    Additional Information:

    Publications

    Responsible Party:
    University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT05761197
    Other Study ID Numbers:
    • 851149
    First Posted:
    Mar 9, 2023
    Last Update Posted:
    Mar 14, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Pennsylvania
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 14, 2023